发明名称 |
AGARICUS BLAZEI MURILL EXTRACTS, METHODS FOR INHIBITING LEGUMAIN USING THE SAME, AND METHODS FOR TREATING TUMORS USING THE SAME |
摘要 |
Extracts of Agaricus blazei Murill have been found to have anti-tumor activity. In particular, a polar, high molecular weight fraction of an Agaricus blazei Murill extract has been found which has an inhibitory effect on legumain activity. Extracts of Agaricus blazei Murill can be used in a pharmaceutical composition to inhibit cysteine protease legumain in a patient suffering from a tumor thereby treating the tumor and preventing new tumors. |
申请公布号 |
US2016166623(A1) |
申请公布日期 |
2016.06.16 |
申请号 |
US201514965309 |
申请日期 |
2015.12.10 |
申请人 |
IMMUNOPHARMA AS |
发明人 |
SAMUELSEN Anne Berit Calmeyer;BERVEN Lise |
分类号 |
A61K36/07 |
主分类号 |
A61K36/07 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for producing a polar, high molecular weight fraction of an Agaricus blazei Murill based extract, comprising:
(a) extracting a lyophilized aqueous preparation of fermented Agaricus blazei Murill with dichloromethane, to obtain a dichloromethane-insoluble material as a first residue; (b) extracting said first residue obtained in (a) with methanol to obtain a methanol-insoluble material as a second residue; (c) extracting said second residue obtained in (b) with a concentrated aqueous solution of ethanol, to obtain an ethanol-insoluble material as a third residue; (d) dissolving said third residue in water and further fractionating it by size, (e) isolating a fraction including compounds with a relatively average molecular weight of about 50 kDa, as determined using oat β-glucan standards, as the polar, high molecular weight fraction. |
地址 |
Hovik NO |